The Institute of Molecular Biology gGmbH (IMB) is a newly established research centre, which is funded by the Boehringer Ingelheim Foundation, a charity with a long tradition in promoting outstanding research in medicine, biology, chemistry and pharmaceutical science. The foundation has dedicated 100 million Euro (approx. 140M US$) for a period of ten years to cover the scientific running of IMB. This generous core funding ensures that our scientists have all it takes to compete at the very forefront of science and allows our groups to embark on long-term innovative projects. IMB is currently headed by its Founding Director, Christof Niehrs.
IMB is housed in a brand-new research building with a modern infrastructure, state-of-the-art scientific facilities and spacious areas for scientific exchange and socialising.
Our aim is to conduct basic and applied research in developmental biology, epigenetics, DNA repair and related biomedical areas. IMB is a non-profit company, but it operates like an academic research centre. Our status does, however, allow us flexible management structures and to remunerate our staff with competitive salaries.
Hierarchies at IMB are deliberately flat, and our research groups enjoy full independence. The working language at IMB is English and we are proud of our international and innovative atmosphere.
We are a young research centre with a clear focus on excellence. By the end of 2013 we aim to have around 150 employees and more than 12 groups, who will be investigating questions at the cutting edge of biomedicine. As such, we offer excellent opportunities for young, ambitious scientists to work in an international and dynamic research environment in the heart of Europe.
To download a PDF of the current IMB flyer, please click here: PDF (7 MB file)